CanNordic a/s: Financial statements 2018
CVR: 33871902
Source: annual report 2018, Danish Business Authority
01/10/2017 – 30/09/2018
CanNordic a/s (CVR 33871902) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 578,819 and a net result of DKK 200,388 compared with DKK -570,931 the year before. Equity in the 2018 report amounted to DKK -1,629,976.
- Gross Profit
- DKK 578,819
- Profit/Loss
- DKK 200,388
- Equity
- DKK -1,629,976
- Total Assets
- DKK 2,679,665
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 579 t. | 200 t. | -1.6 mio. | - |
| 2017 | - | -417 t. | -571 t. | -1.8 mio. | - |
| 2016 | - | -383 t. | -803 t. | -1.3 mio. | - |
| 2015 | - | -84 t. | -542 t. | -456 t. | - |
| 2014 | - | 159 t. | -39 t. | 86 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
CanNordic a/s has published its annual report for 2017. Gross profit came to DKK -416,553, and the net result was DKK -570,931.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.